Searched for
MERIEUX ALLIANCE
Government likens Sanofi’s stake buy in Shantha Biotech to Vodafone caseThe govt in its appeal said that in the McDowell case a five judge bench had held all artificial tax avoidance devices must be brought with...- France, not India, is entitled to Rs 650 crore in capital gains tax from Shantha deal: Andhra High CourtThe judgement is likely to have a calming effect on foreign investors wary about India’s stance on taxing offshore transactions.
- Sanofi seeks French help on possible tax on Shantha dealThe transaction that took place between the sellers and Sanofi Pasteur in 2009 for the acquisition of the French company ShanH was subject ...
- Sanofi's Shantha buyout to attract cap gains taxFrench company Merieux Alliance (MA) held majority stake in Shantha through a subsidiary, ShanH, incorporated outside India.
- I-T Dept to tax over 380 firms for M&A deals in FY'08Having scrutinised more than 380 merger and acquisition deals from 2007-08, the Income Tax department is expected to soon slap entities con...
- I-T lens on 'more cross border' M&AsThe deal of SKR BPO Services with Barclays (H&B ) Mauritius for acquiring Intelnet Global Services is also been examined by the I-T departm...
- Vodafone order to affect IT claims on other cross-border transactionsThe Bombay High Court order will have a bearing on similar cross-border acquisitions on which the tax department has made claims.
- Sanofi in I-T net, told to pay Rs 650 cr over Shantha buyFrench pharma firm Sanofi Aventis, that acquired India's Shantha Biotech last year, has been asked to pay Rs 650 crore as capital gains tax...
- Sanofi in I-T net, told to pay Rs 650 cr over Shantha buyFrench pharma firm Sanofi Aventis, that acquired India's Shantha Biotech last year, has been asked to pay Rs 650 crore as capital gains tax...
- US-based Hospira to buy Orchid Chemicals' injectables biz for $400 mnOrchid Chemicals & Pharmaceuticals to sell its injectables business to the US-based Hospira for around $400 million.
- Pfizer keen to buy Wockhardt's biotech businessThe American company has just completed the $68-billion acquisition of biotech major Wyeth, which is a new drug developer.
- Sanofi-Aventis buys Shantha for Rs 3,740 crThe deal between Sanofi its French owners Meriuex Alliance values the unlisted Indian company at Rs 3,740 crore, or about eight times its p...
- Sanofi buys 80pc stake in Shantha Biotechnics for Rs 3,000 crFrench pharma major Sanofi-aventis today said its vaccine division Sanofi Pasteur has acquired 80 per cent stake in Shantha Biotechnics for...
- Stocks to Watch on FridayInvestors will keep an eye on the GDP figures to be announced later on Friday.
- Glaxo, Sanofi-Aventis eye Shantha BiotechIndia’s Shantha Biotech is on the block, with European drugmakers GlaxoSmithKline and Sanofi-Aventis in separate talks to buy out its Franc...
- Avesthagen to tap capital market for Rs 1,200 croreAvesthagen, a knowledge-based life sciences company, aims to raise between Rs 800 crore and Rs 1,200 crore through an initial public offeri...
- Shantha developing $15 cervical cancer vaccineShantha Biotechnics is developing a vaccine against a virus which causes almost all cases of cervical cancer.
- Merieux, Shantha to hire 100 scientists for research centreShantha Biotech seems to be abuzz with new activity after French healthcare major Merieux Alliance picked up 60% stake in the company last ...
- French Merieux picks up 60% in Shantha BiotechIn a cross-border acquisition in the Indian biotech space, the E1.1-bn French major, Merieux Alliance, has snapped up a 60% stake in Hydera...
- Merieux picks up 60% in Shantha BiotecnicsFrench healthcare company Merieux Alliance on Thursday said it has picked up about 60 per cent stake in Hyderabad-based bio-pharmaceutical ...
Load More- Sanofi's Shantha buyout to attract cap gains tax
